180 related articles for article (PubMed ID: 17138934)
1. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.
Ivanciu L; Gerard RD; Tang H; Lupu F; Lupu C
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):310-6. PubMed ID: 17138934
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
3. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration.
Zhao B; Luo X; Shi H; Ma D
Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846
[TBL] [Abstract][Full Text] [Related]
5. [Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion].
Zhong R; Huang RB; Song SJ
Ai Zheng; 2003 Oct; 22(10):1038-41. PubMed ID: 14558946
[TBL] [Abstract][Full Text] [Related]
6. The role of tissue factor pathway inhibitor-2 in cancer biology.
Sierko E; Wojtukiewicz MZ; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
[TBL] [Abstract][Full Text] [Related]
7. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.
Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R
Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism.
Roca C; Primo L; Valdembri D; Cividalli A; Declerck P; Carmeliet P; Gabriele P; Bussolino F
Cancer Res; 2003 Apr; 63(7):1500-7. PubMed ID: 12670896
[TBL] [Abstract][Full Text] [Related]
10. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
11. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
Sonveaux P; Brouet A; Havaux X; Grégoire V; Dessy C; Balligand JL; Feron O
Cancer Res; 2003 Mar; 63(5):1012-9. PubMed ID: 12615716
[TBL] [Abstract][Full Text] [Related]
12. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
[TBL] [Abstract][Full Text] [Related]
13. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
14. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
15. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression.
Dardik R; Solomon A; Loscalzo J; Eskaraev R; Bialik A; Goldberg I; Schiby G; Inbal A
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1472-7. PubMed ID: 12805075
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.
Konduri SD; Tasiou A; Chandrasekar N; Rao JS
Int J Oncol; 2001 Jan; 18(1):127-31. PubMed ID: 11115549
[TBL] [Abstract][Full Text] [Related]
18. Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line.
Kempaiah P; Kisiel W
Apoptosis; 2008 May; 13(5):702-15. PubMed ID: 18401718
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein enhances angiogenesis and arteriogenesis by modulating smooth muscle cell and macrophage function.
Zbinden S; Wang J; Adenika R; Schmidt M; Tilan JU; Najafi AH; Peng X; Lassance-Soares RM; Iantorno M; Morsli H; Gercenshtein L; Jang GJ; Epstein SE; Burnett MS
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):477-82. PubMed ID: 20056912
[TBL] [Abstract][Full Text] [Related]
20. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
